Elizabeth G Nabel Accolade, Inc. (ACCD) insider trading activity

Elizabeth G Nabel is of Accolade, Inc.. Currently has a direct ownership of 0 shares of ACCD, which is worth approximately $0. The most recent transaction as insider was on Apr 08, 2025, when has been sold 41,982 shares (Common Stock) at a price of $7.03 per share, resulting in proceeds of $295,133. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

ELIZABETH G NABEL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 08 2025	SELL Sale (or disposition) back to the issuer	$295,133 $7.03 p/Share	41,982 Reduced 100.0%	0 Common Stock
Feb 28 2025	BUY Exercise of conversion of derivative security	-	2,178 Added 4.93%	41,982 Common Stock
Dec 02 2024	BUY Exercise of conversion of derivative security	-	2,179 Added 5.19%	39,804 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	-	2,179 Added 5.47%	37,625 Common Stock
Aug 06 2024	BUY Exercise of conversion of derivative security	-	9,196 Added 20.6%	35,446 Common Stock
May 31 2024	BUY Exercise of conversion of derivative security	-	2,179 Added 7.66%	26,250 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	-	1,751 Added 6.78%	24,071 Common Stock
Nov 30 2023	BUY Exercise of conversion of derivative security	-	1,751 Added 7.27%	22,320 Common Stock
Aug 31 2023	BUY Exercise of conversion of derivative security	-	1,752 Added 7.85%	20,569 Common Stock
Jul 25 2023	BUY Exercise of conversion of derivative security	-	14,060 Added 42.77%	18,817 Common Stock
May 31 2023	BUY Exercise of conversion of derivative security	-	1,752 Added 26.92%	4,757 Common Stock
Jul 21 2022	BUY Exercise of conversion of derivative security	-	2,659 Added 46.95%	3,005 Common Stock
Jul 22 2021	BUY Exercise of conversion of derivative security	-	346 Added 50.0%	346 Common Stock

Also insider at

MDT

Medtronic plc Healthcare

Director

MRNA

Moderna, Inc. Healthcare

Director

LYEL

Lyell Immunopharma, Inc. Healthcare

EGN